MAPRE1P3

Across TCGA pan-cancer cohorts, MAPRE1P3 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MAPRE1P3 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MAPRE1P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MAPRE1P3 expression acts as an unfavorable survival marker.

UCEC, KICH, and LUAD are the cancer types where MAPRE1P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.865	0.935	<.001	108	view →
KICH	DFS	Median	III,IV	0.236	0.869	<.001	51	view →
LUAD	OS	Tertile	II,III,IV	0.545	0.726	.004	45	view →
THCA	DFS	Tertile	III,IV	0.146	0.863	<.001	27	view →
OV	OS	Tertile	II,III,IV	0.766	0.849	.045	12	view →
SKCM	OS	Tertile	II,III,IV	0.113	0.324	.016	9	view →
THYM	DFS	Tertile	II,III,IV	0.123	0.841	.021	9	view →
STAD	OS	Tertile	IV	0.111	0.433	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MAPRE1P3–UCEC (OS)

Open the UCEC breakdown →